Výsledky vyhledávání - "Agneta Svedberg"

Akademický článek

Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET

Autor: Simron Singh, Diego Ferone, Jaume Capdevila, Jennifer Ang Chan, Wouter W. de Herder, Daniel Halperin, Josh Mailman, Lisa Hellström, Hanna Liedman, Agneta Svedberg, Fredrik Tiberg

Publikováno v: Trials, Vol 25, Iss 1, Pp 1-13 (2024)

Abstract Background The current standard of care (SoC) for the initial treatment of unresectable or metastatic well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NET) requires initiation of first-generation somatostatin receptor l

Externí odkaz: https://doaj.org/article/6b44dbfb05f04b22bffa74bf3829c11b

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET

Autor: Simron Singh, Diego Ferone, Jaume Capdevila, Jennifer Ang Chan, Wouter W. de Herder, Daniel Halperin, Josh Mailman, Lisa Hellström, Hanna Liedman, Agneta Svedberg, Fredrik Tiberg

Publikováno v: Trials, Vol 25, Iss 1, Pp 1-1 (2024)

Externí odkaz: https://doaj.org/article/1ace9de022f048999908ece1ab83c0f4

Zobrazit plný text záznamu

Plný text ve formátu HTML

Methodology of the SORENTO Clinical Trial: Assessing Efficacy and Safety of High Exposure Octreotide Subcutaneous Depot in Patients with GEP-NET

Autor: MD Simron Singh, MD, PhD Jaume Capdevila, Chan, MD Jennifer Ang, Herder, MD Wouter de, MD, PhD Diego Ferone, MD Daniel Halperin, MBA Josh Mailman, MSc Lisa Hellstrom, MSc, MBA Agneta Svedberg, PhD Fredrik Tiberg

Publikováno v: Endocrine Abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1aa582eb9a5bd7178ac91749377c8bd5
https://doi.org/10.1530/endoabs.89.t7

Zobrazit plný text záznamu

Methodology of the SORENTO clinical trial: Assessing the efficacy and safety of high exposure octreotide subcutaneous depot in patients with GEP-NETs

Autor: Diego Ferone, Jaume Capdevilla, Chan Jennifer Ang, Herder Wouter W de, Daniel Halperin, Josh Mailman, Simron Singh, Mozhgan Dorkhan, Lisa Hellstrom, Agneta Svedberg, Fredrik Tiberg

Publikováno v: Journal of Clinical Oncology. 40:TPS4178-TPS4178

TPS4178 Background: Somatostatin receptor ligands (SRLs) are first-line standard of care therapies for gastroenteropancreatic neuroendocrine tumors (GEP-NETs), showing efficacy in tumor/symptom control with an established safety profile. Yet, disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f457a3375b0a4ccdb86498902219b0ac
https://doi.org/10.1200/jco.2022.40.16_suppl.tps4178

Zobrazit plný text záznamu